Advanced Search
WANG Lijuan, ZOU Lingfeng, GUO Xiaohong, CAO Xiaojing, WANG Junda, ZENG Min. Broad Ligament Lymphangiomyomatosis Misdiagnosed as Low Grade Serous Carcinoma: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 429-432. DOI: 10.3971/j.issn.1000-8578.2021.20.1100
Citation: WANG Lijuan, ZOU Lingfeng, GUO Xiaohong, CAO Xiaojing, WANG Junda, ZENG Min. Broad Ligament Lymphangiomyomatosis Misdiagnosed as Low Grade Serous Carcinoma: A Case Report and Literature Review[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 429-432. DOI: 10.3971/j.issn.1000-8578.2021.20.1100

Broad Ligament Lymphangiomyomatosis Misdiagnosed as Low Grade Serous Carcinoma: A Case Report and Literature Review

Funding: 

Basic Research and Frontier Exploration Project of Natural Science Foundation of Chongqing cstc2019jcyj-msxmX0552

Basic Research and Frontier Exploration Project of Natural Science Foundation of Chongqing cstc2020jcyj-msxmX0568

Xinglin Scholars' Scientific Research Promotion Plan of Chengdu University of Traditional Chinese Medicine YYZX20180023

More Information
  • Corresponding author:

    ZEN Ming, E-mail: 182323712@qq.com

  • Received Date: September 14, 2020
  • Revised Date: December 16, 2020
  • Available Online: January 12, 2024
  • [1]
    王坚, 朱雄增. 软组织病理学[M]. 北京: 人民卫生出版社, 2017: 914-920.

    Wang J, Zhu XZ. Soft tissue pathology[M]. Beijing: People's Medical Pubcishing House Co., LTD, 2017: 914-920.
    [2]
    户彦龙, 张晖, 吴清武, 等. 原发性腹膜后血管周上皮样细胞瘤临床病理及影响特征分析[J]. 实用癌症杂志, 2018, 33(11): 1791-1794. doi: 10.3969/j.issn.1001-5930.2018.11.015

    Hu YL, Zhang H, Wu QW, et al. Clinicopathologic and influence characteristics of primary retroperitoneal perivascular epithelioid cell tumor[J]. Shi Yong Ai Zheng Za Zhi, 2018, 33(11): 1791-1794. doi: 10.3969/j.issn.1001-5930.2018.11.015
    [3]
    杨文圣, 胡君程, 林蓁, 等. 肠系膜淋巴管肌瘤病/淋巴管肌瘤1例及文献复习[J]. 临床与实验病理学杂志, 2011, 27(10): 1136-1138. doi: 10.3969/j.issn.1001-7399.2011.10.032

    Yang WS, Hu JC, Lin Z, et al. Mesenteric lymphangiomyomatosis/lymphangiomyomatosis: a case report and literature review[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2011, 27(10): 1136-1138. doi: 10.3969/j.issn.1001-7399.2011.10.032
    [4]
    朱琳, 周莉, 秦东瑞, 等. 子宫内膜样腺癌合并盆腔淋巴结淋巴管肌瘤病的临床病理分析[J]. 临床与实验病理学杂志, 2017, 33(3): 278-282. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL201703010.htm

    Zhu L, Zhou L, Qin DR, et al. Endometrial endometrioid adenocarcinoma with lymphangiomyomatosis of pelvic lymph node: clinicopathological analysis[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2017, 33(3): 278-282. https://www.cnki.com.cn/Article/CJFDTOTAL-LSBL201703010.htm
    [5]
    孙艳花, 关弘, 温文, 等. 子宫淋巴管肌瘤病临床病理观察[J]. 诊断病理学杂志, 2013, 20(12): 752-755. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDBL201312006.htm

    Sun YH, Guan H, Wen W, et al. Lymphangiomyomatosis of uterus: a clinicopathologic study[J]. Zhen Duan Bing Li Xue Za Zhi, 2013, 20(12): 752-755. https://www.cnki.com.cn/Article/CJFDTOTAL-ZDBL201312006.htm
    [6]
    Ryu JH, Moss J, Beck GJ, et al. The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment[J]. Am J Respir Crit Care Med, 2006, 173(1): 105-111. doi: 10.1164/rccm.200409-1298OC
    [7]
    Fiore MG, Sanguedolce F, Lolli I, et al. Abdominal lymphangioleiomyomatosis in a man with Klinefelter syndrome: The first reported case[J]. Ann Diagn Pathol, 2005, 9(2): 96-100. doi: 10.1016/j.anndiagpath.2004.12.007
    [8]
    Wang XK, Su F, Zhou FF, et al. Sporadic lymphangioleiomyomatosis with multiple atypical features: A case report and literature review[J]. Indian J Pathol Microbiol, 2018, 61(1): 94-97. doi: 10.4103/IJPM.IJPM_843_16
    [9]
    Carel H, Johnson S, Gamble L. Living with lymphangioleiomyomatosis[J]. BMJ, 2010, 340: c848. doi: 10.1136/bmj.c848
    [10]
    王笋, 王蓁, 韩毅, 等. WT-1、Smac蛋白在上皮性卵巢癌中的表达和临床意义研究[J]. 现代生物医学进展, 2018, 18(11): 2136-2140. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201811030.htm

    Wang S, Wang Z, Han Y, et al. A Clinical Study on the WT-1 and Smac Protein Expressions in Epithelial Ovarian Cancer and the Clinical significances[J]. Xian Dai Sheng Wu Yi Xue Jin Zhan, 2018, 18(11): 2136-2140. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201811030.htm
    [11]
    Olpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature[J]. Am J Surg Pathol, 2005, 29(12): 1558-1575. doi: 10.1097/01.pas.0000173232.22117.37
    [12]
    徐晓艳. 15例具有血管周上皮样细胞分化的肿瘤临床病理分析[J]. 临床与实验病理学杂志, 2011, 27(11): 1206-1209. doi: 10.3969/j.issn.1001-7399.2011.11.013

    Xu XY. Clinical and pathological features of perivascular epithelioid cell tumor of 15 cases[J]. Lin Chuang Yu Shi Yan Bing Li Xue Za Zhi, 2011, 27(11): 1206-1209. doi: 10.3969/j.issn.1001-7399.2011.11.013
    [13]
    户彦龙, 张晖, 吴清武, 等. 原发性腹膜后血管周上皮样细胞瘤临床病理及影像特征分析[J]. 实用癌症杂志, 2018, 33(11): 1791-1794. doi: 10.3969/j.issn.1001-5930.2018.11.015

    Hu YL, Zhang H, Wu QW, et al. Analysis of clinicopathological and imaging features of primary retroperitoneal perivascular epithelioid cell tumor[J]. Shi Yong Ai Zheng Za Zhi, 2018, 33 (11): 1791-1794. doi: 10.3969/j.issn.1001-5930.2018.11.015
    [14]
    周婧, 杨树东, 陈文凯, 等. 肺淋巴管平滑肌瘤病中β-catenin的表达及鉴别诊断意义[J]. 诊断病理学杂志, 2015, 22(1): 23-26. doi: 10.3969/j.issn.1007-8096.2015.01.007

    Zhou J, Yang SD, Chen WK, et al. Expression of β-Catenin in pulmonary lymphangioleiomyomatosis and its role in differential diagnostic[J]. Zhen Duan Bing Li Xue Za Zhi, 2015, 22(1): 23-26. doi: 10.3969/j.issn.1007-8096.2015.01.007
    [15]
    Grzegorek I, Lenze D, Chabowski M, et al. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis[J]. Anticancer Res, 2015, 35(6): 3353-3360.
    [16]
    Valencia JC, Steagall WK, Zhang Y, et al. Antibody αPEP13h reacts with lymphangioleiomyomatosis cells in lung nodules[J]. Chest, 2015, 147(3): 771-777. doi: 10.1378/chest.14-0380
    [17]
    Gao L, Yue MM, Davis J, et al. In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor[J]. Virchows Arch, 2014, 464(4): 495-503. doi: 10.1007/s00428-014-1559-9
    [18]
    胡晓文, 徐凯峰. 美国胸科协会和日本呼吸学会淋巴管肌瘤病2016年临床指南简介[J]. 中华结核和呼吸杂志, 2017, 40(10): 727-729. doi: 10.3760/cma.j.issn.1001-0939.2017.10.004

    Hu XW, Xu KF. Introduction of 2016 clinical guidelines for lymphangiomyomatosis of American Thoracic Association and Japanese Respiratory Association[J]. Zhonghua Jie He He Hu Xi Za Zhi, 2017, 40(10): 727-729. doi: 10.3760/cma.j.issn.1001-0939.2017.10.004
    [19]
    Zhou L, Ouyang RY, Luo H, et al. Efficacy of sirolimus for the prevention of recurrent pneumothorax in patients with lymphangioleiomyomatosis: a case series[J]. Orphanet J Rare Dis, 2018, 13(1): 168. doi: 10.1186/s13023-018-0915-2
    [20]
    叶书高, 陈员, 郑明峰, 等. 肺移植治疗肺淋巴管肌瘤病9例临床分析[J]. 中华胸心血管外科杂志, 2019, 35(1): 6-9. doi: 10.3760/cma.j.issn.1001-4497.2019.01.002

    Ye SG, Chen Y, Zheng MF, et al. Lung transplantation for pulmonary lymphangioleiomyomatosis: a report of 9 cases[J]. Zhonghua Xiong Xin Xue Guan Wai Ke Za Zhi, 2019, 35(1): 6-9. doi: 10.3760/cma.j.issn.1001-4497.2019.01.002
  • Related Articles

    [1]ZHENG Liangjian, ZHU Gangfeng, LI Junyan, CHE Jie, CHEN Cixiang, XIANG Yi, SHI Huaqiu. Advances in Research on Lactate Metabolism Disorders and Their Effect on Immunotherapy in Lung Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2024, 51(10): 883-886. DOI: 10.3971/j.issn.1000-8578.2024.24.0334
    [2]JIN Mengru, WANG Li, LI Yanjing. Effect of Lactate on Immune Cells in Tumor Microenvironment and Progress of Related Target Therapy[J]. Cancer Research on Prevention and Treatment, 2023, 50(6): 634-640. DOI: 10.3971/j.issn.1000-8578.2023.22.1076
    [3]YANG Junyuan, CAI Hongbing. Countermeasures and Mechanisms of Drug Resistance in Immunotherapy for Cervical Cancer[J]. Cancer Research on Prevention and Treatment, 2022, 49(9): 886-892. DOI: 10.3971/j.issn.1000-8578.2022.22.0162
    [4]LUO Yiyang, FENG Xiaoli. Research Progress on Relation Between CD47 and Immunotherapy on Lymphoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(8): 799-803. DOI: 10.3971/j.issn.1000-8578.2021.21.0253
    [5]JIN Xin, WU Heshui. Immunotherapy on Pancreatic Cancer: Current Status and Future Perspectives[J]. Cancer Research on Prevention and Treatment, 2020, 47(3): 154-158. DOI: 10.3971/j.issn.1000-8578.2020.19.0993
    [6]LIU Ben, GUO Pengrong, SHENG Yuwen, FU Dewang. Effects of Ganoderma Lucidum Polysaccharide on Chemotherapy Effect and Immune Escape in T24 Bearing Mice[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 459-465. DOI: 10.3971/j.issn.1000-8578.2015.05.008
    [7]XU Weili, CAI Jianhui, LI Suolin, WEN Ming, WEN Junye. Effect of Interfering Tumor Microenvironment on Homing and Killing Activity of Cytotoxic T Lymphocytes[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1286-1291. DOI: 10.3971/j.issn.1000-8578.2014.12.007
    [8]ZHOU Jian, MEI Jia-zhuan, GUO Kun-yuan, NIU Xin-qing, WANG Yang, TU San-fang, ZHOU Xue-yun. Aberrant Expression of NKG2D Ligand and High Expression HLA-Ⅰ Molecules May Contribute to Immune Escape from Natural Killer Cell-mediated Immune Surveillance of Malignant Gliomas[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 247-250. DOI: 10.3971/j.issn.1000-8578.1529
    [9]WANG Zhong, LU Xiang-ming, YUAN Hong-yin. Changes and Significance of Serum Soluble Fas(sFas) and FasL(sFasL) Levels in Patients with Breast Canc[J]. Cancer Research on Prevention and Treatment, 2006, 31(02): 74-76. DOI: 10.3971/j.issn.1000-8578.1053
    [10]LUO Jun, JIN Feng-shuo, LI Qian-shen, JIANG Jun, GAO Lin. The Role of Bladder Cancer Cell in T Cell Functional Inhibition in Vitro[J]. Cancer Research on Prevention and Treatment, 2004, 31(03): 148-150. DOI: 10.3971/j.issn.1000-8578.1085

Catalog

    Corresponding author: ZENG Min, 182323712@qq.com

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Article views (2080) PDF downloads (465) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return